Richard Scott Blackley Sells 28,869 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Blackley sold 28,869 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $907,930.05. Following the sale, the chief financial officer directly owned 1,046,108 shares of the company’s stock, valued at $32,900,096.60. This represents a 2.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Richard Scott Blackley also recently made the following trade(s):

• On Tuesday, August 18th, Richard Blackley sold 18,750 shares of Oscar Health stock. The shares were sold at an average price of $31.74, for a total value of $595,125.00.

Oscar Health Stock Performance

Shares of Oscar Health stock opened at $31.64 on Thursday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The stock’s fifty day moving average is $30.58 and its two-hundred day moving average is $23.14. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $33.55. The company has a market capitalization of $9.77 billion, a PE ratio of 22.60, a price-to-earnings-growth ratio of 0.68 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business’s revenue for the quarter was up 70.4% compared to the same quarter last year. During the same period last year, the company earned ($0.89) earnings per share. As a group, analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have commented on OSCR. Piper Sandler restated an “overweight” rating and issued a $36.00 target price on shares of Oscar Health in a research note on Tuesday, July 28th. Weiss Ratings raised Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Monday, July 6th. Robert W. Baird set a $27.00 target price on Oscar Health in a research report on Friday, August 7th. Finally, Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $26.22.

Institutional Investors Weigh In On Oscar Health

Large investors have recently modified their holdings of the business. Jones Financial Companies Lllp lifted its position in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio bought a new position in shares of Oscar Health during the first quarter valued at approximately $30,000. Fifth Third Bancorp increased its holdings in Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after buying an additional 1,413 shares during the period. CoreCap Advisors LLC increased its holdings in Oscar Health by 526.3% during the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after buying an additional 1,000 shares during the period. Finally, Quarry LP raised its stake in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after buying an additional 1,469 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

Trending Headlines about Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: A recent outlook article argues that Oscar Health’s future remains bright, supported by its technology-driven insurance platform, expanding membership opportunities and potential for continued earnings growth. The future looks bright for Oscar Health stock
• Positive Sentiment: The company’s latest quarterly results were substantially better than expected: earnings per share came in at $1.10 versus the $0.40 consensus estimate, while revenue rose 70.4% year over year to $4.88 billion. Analysts expect full-year EPS of approximately $1.54.
• Positive Sentiment: Institutional ownership remains high at approximately 75.7%, and several funds increased their Oscar Health holdings during the second quarter. Analyst sentiment has also improved in some cases, including a Zacks Research upgrade to “strong buy.”
• Neutral Sentiment: Oscar Health’s chief accounting officer Victoria Baltrus sold 958 shares for $30,129 under a pre-arranged Rule 10b5-1 plan. The filing said the sale covered tax withholding tied to vested equity awards; she retained 213,631 shares. Oscar Health CAO stock sale
• Neutral Sentiment: Director Mario Schlosser, CFO Richard Blackley, Adam Mcananey and Janet Liang also reported stock sales totaling roughly $2.5 million. Each transaction was conducted under a 10b5-1 plan and attributed to tax obligations, while all sellers retained sizable positions.
• Negative Sentiment: The cluster of insider selling may nevertheless weigh on sentiment, particularly because the transactions occurred near OSCR’s 52-week high. The stock’s average analyst rating remains “hold,” with a consensus price target of $26.22, below recent trading levels.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.